|
1
|
Liu BB and Wang WH: Survivin and
pancreatic cancer. World J Clin Oncol. 2:164–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kelly RJ, Lopez-Chavez A, Citrin D, Janik
JE and Morris JC: Impacting tumor cell-fate by targeting the
inhibitor of apoptosis protein survivin. Mol Cancer. 10:352011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamamoto H, Ngan CY and Monden M: Cancer
cells survive with survivin. Cancer Sci. 99:1709–1714. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennati M, Folini M and Zaffaroni N:
Targeting survivin in cancer therapy. Expert Opin Ther Targets.
12:463–476. 2008. View Article : Google Scholar
|
|
5
|
Fukuda S and Pelus LM: Survivin, a cancer
target with an emerging role in normal adult tissues. Mol Cancer
Ther. 5:1087–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao C, Mu Y, Hallahan DE and Lu B: XIAP
and survivin as therapeutic targets for radiation sensitization in
preclinical models of lung cancer. Oncogene. 23:7047–7052. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma H, Sen S, Lo Muzio L, Mariggiò A
and Singh N: Antisense-mediated downregulation of anti-apoptotic
proteins induces apoptosis and sensitizes head and neck squamous
cell carcinoma cells to chemotherapy. Cancer Biol Ther. 4:720–727.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du ZX, Zhang HY, Gao da X, Wang HQ, Li YJ
and Liu GL: Antisurvivin oligonucleotides inhibit growth and induce
apoptosis in human medullary thyroid carcinoma cells. Exp Mol Med.
38:230–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fuessel S, Kueppers B, Ning S, Kotzsch M,
Kraemer K, Schmidt U, Meye A and Wirth MP: Systematic in vitro
evaluation of survivin directed antisense oligodeoxynucleotides in
bladder cancer cells. J Urol. 171:2471–2476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Chen ZD, Du CJ, Xu G and Luo W:
siRNA targeting survivin inhibits growth and induces apoptosis in
human renal clear cell carcinoma 786-O cells. Pathol Res Pract.
205:823–827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li QX, Zhao J, Liu JY, Jia LT, Huang HY,
Xu YM, Zhang Y, Zhang R, Wang CJ, Yao LB, Chen SY and Yang AG:
Survivin stable knockdown by siRNA inhibits tumor cell growth and
angiogenesis in breast and cervical cancers. Cancer Biol Ther.
5:860–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hobert O: Gene regulation by transcription
factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
14
|
Greither T, Grochola LF, Udelnow A,
Lautenschläger C, Würl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikenaga N, Ohuchida K, Mizumoto K, Yu J,
Kayashima T, Sakai H, Fujita H, Nakata K and Tanaka M: MicroRNA-203
expression as a new prognostic marker of pancreatic adenocarcinoma.
Ann Surg Oncol. 17:3120–3128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bueno MJ, Pérez de Castro I, Gómez de
Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM,
Fernández-Piqueras J and Malumbres M: Genetic and epigenetic
silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene
expression. Cancer Cell. 13:496–506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Viticchiè G, Lena AM, Latina A, Formosa A,
Gregersen LH, Lund AH, Bernardini S, Mauriello A, Miano R, Spagnoli
LG, Knight RA, Candi E and Melino G: MiR-203 controls
proliferation, migration and invasive potential of prostate cancer
cell lines. Cell Cycle. 10:1121–1131. 2011.PubMed/NCBI
|
|
18
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H,
Calin GA, Menard S and Croce CM: MicroRNA signatures in human
ovarian cancer. Cancer Res. 67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F,
Gomella LG, Croce CM and Baffa R: Micro-RNA profiling in kidney and
bladder cancers. Urol Oncol. 25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu
CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei W, Wanjun L, Hui S, Dongyue C, Xinjun
Y and Jisheng Z: miR-203 inhibits proliferation of HCC cells by
targeting survivin. Cell Biochem Funct. 31:82–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bian K, Fan J, Zhang X, Yang XW, Zhu HY,
Wang L, Sun JY, Meng YL, Cui PC, Cheng SY, Zhang J, Zhao J, Yang AG
and Zhang R: MicroRNA-203 leads to G1 phase cell cycle arrest in
laryngeal carcinoma cells by directly targeting survivin. FEBS
Lett. 586:804–809. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang F, Xue X, Wei J, An Y, Yao J, Cai H,
Wu J, Dai C, Qian Z, Xu Z and Miao Y: hsa-miR-520h downregulates
ABCG2 in pancreatic cancer cells to inhibit migration, invasion,
and side populations. Br J Cancer. 103:567–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu
D and Huang Y: microRNA-203 suppresses bladder cancer development
by repressing bcl-w expression. FEBS J. 278:786–792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Chen Y, Zhao J, Kong F and Zhang Y:
miR-203 reverses chemoresistance in p53-mutated colon cancer cells
through downregulation of Akt2 expression. Cancer Lett. 304:52–59.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saini S, Arora S, Majid S, Shahryari V,
Chen Y, Deng G, Yamamura S, Ueno K and Dahiya R: Curcumin modulates
microRNA-203-mediated regulation of the Src-Akt axis in bladder
cancer. Cancer Prev Res (Phila). 4:1698–1709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J,
Cheng HZ and Huang SD: MicroRNA-203 inhibits cell proliferation by
repressing ΔNp63 expression in human esophageal squamous cell
carcinoma. BMC Cancer. 11:572011.
|
